Navigation Links
Amilpar - Relevant Fact - Public Offer
Date:12/9/2009

RIO DE JANEIRO, Dec. 9 /PRNewswire-FirstCall/ -- Amilpar (Bovespa: AMIL3; Bloomberg: AMIL3 BZ and APAR < GO >; Reuters: AMIL3.SA), the largest managed care organization in Brazil, in addition to the Relevant Facts released on November 19, 2009 and December 2, 2009, informs its shareholders and the market that the initiatives to proceed with the Public Offer defined below were started today, having as Applicant its subsidiary AMIL ASSISTENCIA MEDICA INTERNACIONAL LTDA. The filing to register the public offer for the acquisition of shares issued by Medial Saude S.A. ("Medial") due to the control change, at the price of R$ 17.2066 per share, along with the exit from Novo Mercado and delisting of the company was done at CVM - Comissao de Valores Mobiliarios (Brazilian Securities and Exchange Commission), according to article 254-A of Law 6,404/76, CVM Instruction 361/02, BM&FBovespa's Novo Mercado Regulation and the Bylaws of Medial Saude S.A. ("Public Offer").

Amilpar informs that Medial's economic value per share is subject to confirmation through the valuation report to be prepared according to BM&FBovespa's Novo Mercado rules.

Amilpar will keep the market and its shareholders informed about the conclusion of the above-mentioned offer.

    To access the Relevant Fact, visit our website at www.amilpar.com.br/ir

    IR Contact
    Erwin Kleuser
    Investor Relations Officer
    Phone: +55 (21) 3805-1155
    invest@amil.com.br
    www.amilpar.com.br/ir

SOURCE Amilpar


'/>"/>
SOURCE Amilpar
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Amilpar - Revenues Grow 8% and Net Income Improves 28% in 3Q09
2. Amilpar - Operating Revenues Grew 9% in the Second Quarter and 11% in the First Half of 2009
3. Amilpar - Revenue Increases 13.4% and Medical Loss Ratio Falls in the First Quarter 2009
4. Amilpar - Revenues Increase by 26.5% and Adjusted Net Income Climbs 28.7% in 2008
5. Amilpar - Notice to Shareholders - Distribution of Interest on Capital Stock
6. Amilpar Revenues Grow 28% in the First 9 Months of 2008 and 4.5% Over Previous Quarter
7. Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007
8. Healthcare Organizations Face Tough Marketing Challenges - GY&K Asks Are You Relevant?
9. Relevant Security and bitRail Debut RevSecure Product Line
10. 30th Anniversary Edition of Mandell, Douglas, and Bennetts Principles and Practice of Infectious Diseases is More Relevant Than Ever
11. www.greatplacesinc.com Isthe Leading Internet Resourcefor Current, Relevant, Reliable Advice,Counseling the 76 MillionBaby Boomers Who Are Increasingly Responsible for Their Aging Parents' Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2017)... , ... May 27, 2017 , ... Most us are ... but a new study from the Osteoarthritis Initiative shows that certain people ... osteoarthritis. Knowing this in advance may give doctors the opportunity to treat patients before ...
(Date:5/26/2017)... ... May 26, 2017 , ... The American Parkinson Disease ... than eighty-nine grant submissions all vying for nearly $1,000,000 in funding that will ... , The American Parkinson Disease Association (APDA) is focused on advancing scientific research ...
(Date:5/26/2017)... ... May 26, 2017 , ... The Radiology ... to focus on current legislative activity and the latest regulatory concerns impacting RBMA ... Sunday, Sept. 10, and will continue through Monday, Sept. 11, at the Ritz-Carlton, ...
(Date:5/26/2017)... ... May 26, 2017 , ... Somnoware, a leading provider of ... with its Somnoware Sleep Device Interface (SDI). Somnoware SDI is a sleep device ... this platform, initializing devices and importing studies are just one-click operations. This plugin ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... is sharing bold recipes for Memorial Day entertaining that are sure to satisfy ... “Boar’s Head fresh sliced meats and cheeses featured in these refreshingly balanced recipes ...
Breaking Medicine News(10 mins):
(Date:5/8/2017)... , May 8, 2017  Diplomat Pharmacy, Inc. (NYSE: ... Inc. ("WRB"), a health care service center company ... WRB specializes in relationship management programs for leading ... WRB will join Envoy ... support services for manufacturers, biotech firms, and other service ...
(Date:5/4/2017)... MEMPHIS, Tenn. , May 4, 2017 /PRNewswire/ ... of Infection Control, Ultraviolet-C light as ... demonstrated Tru-D SmartUVC,s ability to reduce bioburden on ... influenced bioburden reduction on high-touch, complex medical equipment ... in surgical infections. "This study further ...
(Date:5/4/2017)... 4, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade hypothermic storage ... "Company"), today announced that the Company,s first quarter 2017 ... Thursday, May 11, 2017, and that the Company will ... p.m. PT that afternoon. Management will provide an overview ...
Breaking Medicine Technology: